Visual field constriction is not limited to children treated with vigabatrin

Neuropediatrics

Volumn 30, Issue 3, 1999, Pages 130-132

  Wohlrab, Gabriele ^a   Boltshauser, E ^a   Schmitt, B ^a   Schriever, Steffi ^b   Landau, Klara ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Childhood epilepsy; Vigabatrin; Visual field constriction

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; OXCARBAZEPINE; VALPROIC ACID; VIGABATRIN;

ABSENCE; ADOLESCENT; ADULT; ARTICLE; CHILD; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; HUMAN; INFANT; INFANTILE SPASM; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; OPHTHALMOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

EID: 0032792669     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973477     Document Type: Article

References (19)

1. Aicardi, J., Sabril, I. S. Investigator and Peer Review Groups. In: Mumford, J. P., Dumas, C., Wood, S. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Epilepsia 37, 638-642 (1996)
2. Backstrom, J. T., Hinkle, R. L., Flicker, M. R. Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies. BMJ 314, 1694-1695 (Letter) (1997)
3. Baulac, M., Nordmann, J. P., Lanoé, Y. Severe visual field constriction and side-effects of GABA-mimetic antiepileptic agents. The Lancet 352, 546 (Letter) (1998)
4. Baulac, M., Nordmann, J. P., Lanoé, Y. Visual field (VF) constriction: one case associated with progabide and phenobarbital and three cases of worsening preexisting VF defects in presence of vigabatrin. Epilepsia 39 (Suppl. 6), 46 (1998)
5. Blackwell, N., Hayllar, J., Kelly, G. Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing. BMJ 314, 1694 (Letter) (1997)
6. Collins, S., Brun, S., Kirstein, Y. G., Sommerville, K. W. Absence of visual field defects in patients taking tiagabine. Epilepsia 39 (Suppl. 6), 146-147 (1998)
7. Eke, T., Talbot, J. F., Lawden, M. C. Severe persistent visual field constriction associated with vigabatrin. BMJ 314, 180-181 (1997)
8. Harding, G. F. A. Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist. BMJ 314, 1694 (Letter) (1997)
9. Harding, G. F. A. Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients. BMJ 316, 232-233 (Letter) (1998)
10. Krauss, G. L., Johnson, M. A., Miller, N. R. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings. Neurology 50, 614-618 (1998)
11. Lawden, M. C., Eke, T., Degg, C., Harding, G., Wild, J. Visual field constriction associated with vigabatrin treatment. Neuro-Ophthalmology 20, 17 (1998)
12. Leach, J. P., Rao, P., Ahlfat, F., Kyle, G., Chadwick, D. W. Vigabatrin and visual field defects: is there a link? Epilepsia 39 (Suppl. 6), 58 (1998)
13. Mackenzie, R., Klistorner, A. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ 316, 233 (Letter) (1998)
14. Mumford, J. P., Cannon, D. J. Vigabatrin. Epilepsia 35 (Suppl. 5), S25-S28 (1994)
15. Ruether, K., Pung, T., Kellner, U., Schmitz, B., Hartmann, C., Seeliger, M. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. Arch. Ophthalmol. 116, 817-819 (1998)
16. Vles, J. S. H., van der Heyden, A. M. H. G., Ghijs, A., Troost, J. Vigabatrin in the treatment of infantile spasms. Neuropediatrics 24, 230-231 (1993)
17. Wilson, E. A., Brodie M. J. Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions. BMJ 314, 1693 (Letter) (1997)
18. Wohlrab, G., Boltshauser, E., Schmitt, B. Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome. Neuropediatrics 29, 133-136 (1998)
19. Wong, I. C. O., Mawer, G. E., Sander, J. W. A. S. Severe persistent visual field constriction associated with vigabatrin. Reaction may be dose dependent. BMJ 314, 1693-1694 (Letter) (1997)